European Pharmaceutical Contract Manufacturing Market
European Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Manufacturing Process Type (Sterile Manufacturing, and Non-Sterile Manufacturing) By Product Type (OTC, API, Finished Dosage Formulation, and Others) By Route of Administration (Oral, Inhaled, Parenteral, and Others) By Service (R&D, Manufacturing, and Non-Clinical) Forecast 2026-2035
Industry Overview
European pharmaceutical contract manufacturing market was valued at $47.9 billion in 2025 and is projected to reach $108.1 billion by 2035, growing at a CAGR of 8.5% during the forecast period (2026–2035). The European pharmaceutical contract manufacturing market is experiencing steady growth as drug developers seek reliable partners to support complex production needs. Companies are turning to external manufacturers to manage rising regulatory demands and to secure access to advanced technologies without expanding their own facilities. This shift is also influenced by the increasing number of sophisticated therapies that require specialized handling and controlled environments. Contract manufacturers offering strong technical expertise and flexible capacity are seeing higher engagement from both established and emerging pharmaceutical firms. As cost pressures intensify, outsourcing is becoming a practical strategy for maintaining operational efficiency.
Market Dynamics
Increasing Demand for Specialized and High-Value Manufacturing
Growing reliance on complex therapies is driving pharmaceutical companies in Europe to outsource advanced manufacturing tasks to experienced contract partners. The market is witnessing a notable shift toward biologics, sterile injectables, and high-potency APIs, requiring highly controlled production environments. As firms prioritize efficiency and regulatory compliance, CMOs with specialized capabilities are gaining stronger traction. This trend is further supported by rising R&D investments and the need for rapid scale-up of innovative therapies. Overall, demand for high-value, technologically advanced manufacturing continues to expand across the region.
Expansion of Flexible and Scalable Production Model
European CMOs are increasingly adopting modular, flexible, and rapid-deployment manufacturing systems to support varying batch sizes and faster product launches. The shift toward personalized medicine and small-volume biologics is accelerating the need for adaptable capacity and agile production workflows. Companies are prioritizing scalable facilities that can quickly adjust to changing client requirements and regulatory expectations. This approach enhances operational resilience while reducing time-to-market for new therapies. As a result, flexible manufacturing solutions are becoming a central competitive advantage in the European CMO landscape.
Market Segmentation
- Based on the manufacturing process type, the market is segmented into sterile manufacturing and non-sterile manufacturing.
- Based on the product type, the market is segmented into OTC, API, finished dosage formulation, and others.
- Based on the route of administration, the market is segmented into oral, inhaled, parenteral, and others.
- Based on the service, the market is segmented into R&D, manufacturing, and non-clinical.
Non-Sterile Manufacturing Segment to Lead the Market with the Largest Share
The demand for non-sterile production services is supporting a steady expansion of the contract manufacturing landscape across Europe. Many pharmaceutical companies prefer to outsource these operations to gain access to optimized facilities and well-established quality systems. This arrangement helps them manage routine formulations more efficiently while focusing internal resources on priority projects. Contract manufacturers offering broad non-sterile capabilities are benefiting from consistent project volumes and long-term partnerships. As product portfolios diversify, the need for flexible non-sterile capacity continues to rise. This shift is contributing to a wider reliance on external manufacturing support throughout the region.
Manufacturing: A Key Segment in Market Growth
Growth in the European contract manufacturing market is being influenced by the wider use of external production services across various therapeutic categories. Pharmaceutical firms are increasingly engaging specialized partners to handle formulation, scaling, and packaging activities that require technical precision. This collaborative approach allows companies to streamline operations and improve delivery timelines without expanding internal infrastructure. Providers with proven expertise and reliable capacity are attracting strong interest from both large and mid-sized developers. As manufacturing expectations evolve, outsourcing offers a practical route to keep pace with changing requirements. These dynamics are contributing to the market’s continued progress.
Regional Outlook
European pharmaceutical contract manufacturing market is further divided by countries, including the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe.
Germany Dominates the Market with Major Share
Germany’s contract manufacturing sector is gaining momentum as pharmaceutical companies look for dependable partners to support their production goals. The country’s strong regulatory framework and advanced technical environment make it an appealing destination for outsourced projects. Many firms prefer working with local manufacturers to ensure consistency, quality, and timely delivery. This trend is particularly evident among developers seeking efficient solutions for both routine and specialized products. As competition increases, businesses are relying more on external expertise to maintain operational balance.
Market Players Outlook
The major companies operating in the European pharmaceutical contract manufacturing market include Boehringer Ingelheim BioXcellence, Catalent Pharma Solutions, Inc., Lonza Group AG, Patheon Pharmaceuticals (Thermo Fisher Scientific), Siegfried Holding AG, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In May 2025, FAMAR Group, a European pharmaceutical CDMO, announced the signature of an agreement to acquire a sterile production site in Homburg (Saar), Germany, from MiP Pharma. The acquisition represents a strategic milestone in FAMAR’s growth journey, strengthening its footprint in high-value dosage forms and expanding its capabilities in aseptic and lyophilized fill & finish.
- In October 2024, Aenova, one of the contract development and manufacturing organizations (CDMO), strengthened its development services, in particular in the areas of formulation and pre-formulation as well as clinical trial services. Aenova offers its customers an even wider range of end-to-end services in the product life cycle of a drug. The pharmaceutical development market is becoming increasingly complex, with drug discovery and biopharmaceutical companies having a portfolio of molecules that are more difficult than ever to deliver to the human body and to formulate into finished dosage forms.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the European pharmaceutical contract manufacturing market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- European Pharmaceutical Contract Manufacturing Market Sales Analysis – Manufacturing Process | Product Type | Route of Administration | Services | ($ Million)
- European Pharmaceutical Contract Manufacturing Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key European Pharmaceutical Contract Manufacturing Industry Trends
- Market Recommendations
- Market Determinants
- Market Drivers
- Drivers For European Pharmaceutical Contract Manufacturing Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For European Pharmaceutical Contract Manufacturing Market: Impact Analysis
- Market Opportunities
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – European Pharmaceutical Contract Manufacturing Market Revenue and Share by Manufacturers
- Pharmaceutical Contract Manufacturing Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Boehringer Ingelheim BioXcellence
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Catalent Pharma Solutions, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Lonza Group AG
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Patheon Pharmaceuticals (Thermo Fisher Scientific)
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Siegfried Holding AG
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Boehringer Ingelheim BioXcellence
- Key Company Analysis
- European Pharmaceutical Contract Manufacturing Market Sales Analysis by Manufacturing Process ($ Million)
- Sterile Manufacturing
- Non-Sterile Manufacturing
- European Pharmaceutical Contract Manufacturing Market Sales Analysis by Product Type ($ Million)
- Over-The-Counter (OTC) Drugs
- Active Pharmaceutical Ingredients (API)
- Finished Dosage Formulation
- Solid Dose
- Liquid Dose
- Injectable Dose
- Others (Nutritional Products and Packaging)
- European Pharmaceutical Contract Manufacturing Market Sales Analysis by Route of Administration ($ Million)
- Oral
- Inhaled
- Parenteral
- Others (Rectal and Vaginal)
- European Pharmaceutical Contract Manufacturing Market Sales Analysis by Services ($ Million)
- R&D
- Manufacturing
- Non-Clinical Service Such as Supply Chain Management
- Regional Analysis
- European Pharmaceutical Contract Manufacturing Market Sales Analysis – Manufacturing Process | Product Type | Route of Administration | Services | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Company Profiles
- Aenova Group
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ardena Group
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Baxter BioPharma Solutions
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Boehringer Ingelheim BioXcellence
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Catalent Pharma Solutions, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Delpharm Group
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Evotec SE
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- FAMAR Health Care Services
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Fareva Group
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Helsinn Advanced Synthesis SA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Lonza Group AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Minakem (Minafin Group)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- NextPharma Technologies
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Patheon Pharmaceuticals (Thermo Fisher Scientific)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- PCI Pharma Services
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Pierre Fabre Contract Manufacturing
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Pierre Fabre Contract Manufacturing
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sandoz Contract Manufacturing
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Siegfried Holding AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Vetter Pharma-Fertigung GmbH & Co. KG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Aenova Group
1. European Pharmaceutical Contract Manufacturing Market Research and Analysis by Manufacturing Process, 2025–2035 ($ Million)
2. European Sterile Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
3. European Non-Sterile Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
4. European Pharmaceutical Contract Manufacturing Market Research and Analysis by Product Type, 2025–2035 ($ Million)
5. European OTC Drugs Contract Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
6. European Active Pharmaceutical Ingredients (API) Contract Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
7. European Finished Dosage Formulation Contract Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
8. European Others Contract Manufacturing Product Type Market Research and Analysis by Region, 2025–2035 ($ Million)
9. European Pharmaceutical Contract Manufacturing Market Research and Analysis by Route of Administration, 2025–2035 ($ Million)
10. European Oral Drug Contract Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
11. European Inhaled Drug Contract Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
12. European Parenteral Drug Contract Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
13. European Other Route of Administration Contract Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
14. European Pharmaceutical Contract Manufacturing Market Research and Analysis by Services, 2025–2035 ($ Million)
15. European Pharmaceutical Contract Manufacturing For R&D Services Market Research and Analysis by Region, 2025–2035 ($ Million)
16. European Pharmaceutical Contract Manufacturing For Manufacturing Services Market Research and Analysis by Region, 2025–2035 ($ Million)
17. European Pharmaceutical Contract Manufacturing For Non-Clinical Services (Supply Chain Management) Market Research and Analysis by Region, 2025–2035 ($ Million)
18. European Pharmaceutical Contract Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
19. European Pharmaceutical Contract Manufacturing Market Research and Analysis by Country, 2025–2035 ($ Million)
20. European Pharmaceutical Contract Manufacturing Market Research and Analysis by Manufacturing Process, 2025–2035 ($ Million)
21. European Pharmaceutical Contract Manufacturing Market Research and Analysis by Product Type, 2025–2035 ($ Million)
22. European Pharmaceutical Contract Manufacturing Market Research and Analysis by Route of Administration, 2025–2035 ($ Million)
23. European Pharmaceutical Contract Manufacturing Market Research and Analysis by Service, 2025–2035 ($ Million)
1. European Pharmaceutical Contract Manufacturing Market Share by Manufacturing Process, 2025 Vs 2035 (%)
2. European Sterile Manufacturing Market Share by Region, 2025 Vs 2035 (%)
3. European Non-Sterile Manufacturing Market Share by Region, 2025 Vs 2035 (%)
4. European Pharmaceutical Contract Manufacturing Market Share by Product Type, 2025 Vs 2035 (%)
5. European OTC Drugs Contract Manufacturing Market Share by Region, 2025 Vs 2035 (%)
6. European Active Pharmaceutical Ingredients (API) Contract Manufacturing Market Share by Region, 2025 Vs 2035 (%)
7. European Finished Dosage Formulation Contract Manufacturing Market Share by Region, 2025 Vs 2035 (%)
8. European Other Contract Manufacturing Product Type Market Share by Region, 2025 Vs 2035 (%)
9. European Pharmaceutical Contract Manufacturing Market Share by Route of Administration, 2025 Vs 2035 (%)
10. European Oral Drug Contract Manufacturing Market Share by Region, 2025 Vs 2035 (%)
11. European Inhaled Drug Contract Manufacturing Market Share by Region, 2025 Vs 2035 (%)
12. European Parenteral Drug Contract Manufacturing Market Share by Region, 2025 Vs 2035 (%)
13. European Other Route Of Administration Contract Manufacturing Market Share by Region, 2025 Vs 2035 (%)
14. European Pharmaceutical Contract Manufacturing Market Share by Services, 2025 Vs 2035 (%)
15. European Pharmaceutical Contract Manufacturing For R&D Services Market Share by Region, 2025 Vs 2035 (%)
16. European Pharmaceutical Contract Manufacturing For Manufacturing Services Market Share by Region, 2025 Vs 2035 (%)
17. European Pharmaceutical Contract Manufacturing For Non-Clinical Services (Supply Chain Management) Market Share by Region, 2025 Vs 2035 (%)
18. European Pharmaceutical Contract Manufacturing Market Share by Region, 2025 Vs 2035 (%)
19. Germany Pharmaceutical Contract Manufacturing Market Size, 2025–2035 ($ Million)
20. UK Pharmaceutical Contract Manufacturing Market Size, 2025–2035 ($ Million)
21. France Pharmaceutical Contract Manufacturing Market Size, 2025–2035 ($ Million)
22. Spain Pharmaceutical Contract Manufacturing Market Size, 2025–2035 ($ Million)
23. Italy Pharmaceutical Contract Manufacturing Market Size, 2025–2035 ($ Million)
24. Russia Pharmaceutical Contract Manufacturing Market Size, 2025–2035 ($ Million)
25. Rest of European Pharmaceutical Contract Manufacturing Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
